Book Cover
Home  |   Healthcare   |  External Defibrillators Market

External Defibrillators Market Size, Share, Growth, and Industry Analysis, By Type (Automatic Type,Manually Type), By Application (Pulseless Ventricular Tachycardia,Ventricular Fibrillation, Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

External Defibrillators Market Overview

The global External Defibrillators Market is forecast to expand from USD 6474.31 million in 2026 to USD 7004.56 million in 2027, and is expected to reach USD 13144.57 million by 2035, growing at a CAGR of 8.19% over the forecast period.

The External Defibrillators Market has become one of the most critical segments in the global medical devices industry, driven by the growing prevalence of cardiac arrest cases worldwide. According to the World Health Organization, an estimated 17.9 million people die annually from cardiovascular diseases, representing approximately 32% of all global deaths. Among these, over 7 million cases involve sudden cardiac arrest (SCA), with survival rates below 10% when no defibrillation occurs within the first few minutes. Over 85% of out-of-hospital cardiac arrests occur in public or residential settings, underscoring the need for widespread availability of external defibrillators. By 2025, more than 5.2 million external defibrillators are expected to be installed globally, including public access defibrillators (PADs), hospital-based systems, and emergency response units.

In the United States, the External Defibrillators Market demonstrates significant penetration, supported by strict public health initiatives and government regulations mandating automated external defibrillators (AEDs) in public areas. More than 356,000 out-of-hospital cardiac arrests are reported annually in the U.S., with only about 12% survival rates. Approximately 65% of U.S. public facilities, including airports, schools, and offices, have AED installations. The American Heart Association reports that rapid defibrillation within three minutes increases survival by up to 70%. More than 850,000 AED units are currently in circulation across hospitals, clinics, and community centers in the United States, with annual installations exceeding 55,000 new units.

Global External Defibrillators Market Size,

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: Approximately 78% of market growth is driven by the rising incidence of cardiac arrhythmias and sudden cardiac arrests, particularly in aging populations over 60 years.
  • Major Market Restraint: Around 42% of potential users face barriers due to high equipment costs and maintenance requirements for battery and electrode replacements.
  • Emerging Trends: Nearly 63% of new products now integrate IoT connectivity, cloud data monitoring, and AI-based rhythm analysis for improved patient outcomes.
  • Regional Leadership: North America holds around 46% of the global market share, followed by Europe at 28%, and Asia-Pacific at 21%, highlighting significant regional adoption.
  • Competitive Landscape: Approximately 60% of total device distribution is concentrated among top five manufacturers, including Philips Healthcare, ZOLL, and Nihon Kohden.
  • Market Segmentation: Nearly 54% of demand comes from automatic external defibrillators (AEDs), while manual defibrillators account for about 38%, and wearable defibrillators contribute the remaining share.
  • Recent Development: Around 35% of companies launched next-generation defibrillators between 2023–2025 featuring remote data logging and self-testing functions.

The External Defibrillators Market Trends indicate a strong shift toward technological integration, portability, and smart connectivity. More than 67% of manufacturers now incorporate Bluetooth and Wi-Fi modules, enabling real-time monitoring and data transfer to emergency services. Wearable defibrillator technology has also grown, with approximately 95,000 wearable units in use globally as of 2025, mainly for patients at high risk of sudden cardiac arrest. Automated self-testing features have become standard in over 70% of modern AEDs, reducing maintenance errors.

Furthermore, around 58% of hospitals in Europe and North America have implemented centralized defibrillation response systems that link all hospital departments through connected AEDs. AI-enabled rhythm interpretation now achieves over 98% accuracy in detecting ventricular fibrillation and pulseless ventricular tachycardia. In addition, 40% of new devices now support multilingual voice instructions, enhancing accessibility across diverse environments. These factors illustrate a growing convergence of healthcare digitalization with emergency life-support technology, significantly shaping External Defibrillators Market Growth and External Defibrillators Market Opportunities worldwide.

External Defibrillators Market Dynamics

DRIVER

"Rising prevalence of cardiovascular diseases and sudden cardiac arrests."

Globally, the incidence of cardiac arrests is estimated at 7 million cases per year, with survival rates increasing by up to 75% when immediate defibrillation is applied. With over 1.3 billion people aged 60 and above by 2030, demand for external defibrillators is expanding rapidly. In hospitals, 23% of cardiac events require defibrillation, and more than 90% of ambulance services now use AEDs or manual defibrillators. Public access initiatives in Japan, the UK, and the U.S. have resulted in over 2.1 million installed AEDs in public areas by 2025, further supporting market expansion.

RESTRAINT

"Limited affordability and accessibility in low-income regions."

About 41% of developing nations still lack adequate AED coverage due to high device costs and limited healthcare infrastructure. Annual maintenance, including battery and electrode pad replacements, can cost up to 12% of total device value, discouraging adoption. Additionally, a shortage of trained personnel in rural regions restricts effective use; only 28% of community responders are trained in defibrillator operation in developing areas. These factors limit External Defibrillators Market Penetration in emerging economies.

OPPORTUNITY

"Integration of AI and IoT for predictive monitoring and smart response systems."

AI-integrated external defibrillators can predict abnormal rhythms with 95% accuracy and automatically alert emergency teams. More than 30 global companies are now developing AI-assisted defibrillation platforms, expected to reduce response times by up to 40%. IoT integration enables cloud-based maintenance and real-time status reporting, improving uptime reliability from 85% to 98%. Such technological advancements open new External Defibrillators Market Opportunities in both hospital and public access segments.

CHALLENGE

"Regulatory compliance and interoperability across regions."

Around 57% of manufacturers report challenges in meeting region-specific certification standards such as FDA (U.S.), CE (Europe), and PMDA (Japan). Variations in data format standards and communication protocols hinder cross-border device integration. Additionally, 33% of recalls between 2021 and 2024 were related to software and connectivity issues. These regulatory inconsistencies pose obstacles to External Defibrillators Market Expansion at a global scale.

External Defibrillators Market Segmentation

Global External Defibrillators Market Size, 2035 (USD Million)

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

By Type

Automatic Type: Automatic external defibrillators (AEDs) dominate the market, accounting for approximately 54% of total units installed globally. Around 80% of AEDs are used outside hospital environments, such as in offices, airports, and schools. AEDs are designed for minimal user intervention, with automated rhythm detection and shock delivery, improving survival rates from 7% to 65% in public cardiac emergencies. The market has witnessed a 32% increase in installations over the past three years, driven by government mandates in over 45 countries requiring AEDs in public facilities.

Manual Type: Manual defibrillators represent about 38% of market usage, primarily in hospitals and ambulances. They provide precise control over energy levels and require trained healthcare professionals for operation. Approximately 97% of emergency response vehicles in North America and Europe are equipped with manual defibrillators. Clinical studies show manual defibrillation reduces hospital mortality by 28% in intensive care units. Technological improvements, including advanced ECG monitoring and synchronization capabilities, have enhanced their reliability and performance.

By Application

Pulseless Ventricular Tachycardia (PVT): External defibrillators are crucial for treating pulseless ventricular tachycardia, which accounts for 26% of in-hospital cardiac arrests. Immediate defibrillation within 120 seconds can improve survival by up to 60%. Over 1.5 million hospital defibrillation events each year are linked to PVT management. Advanced defibrillators now deliver energy levels between 150–360 joules, improving rhythm recovery rates significantly.

Ventricular Fibrillation (VF): Ventricular fibrillation represents nearly 64% of sudden cardiac arrest cases globally. Rapid defibrillation is vital, as survival decreases by 7–10% for every minute delay in shock delivery. Modern AEDs can analyze VF patterns within 8 seconds and deliver a shock automatically. Around 75% of AED interventions in public areas involve VF cases, emphasizing their importance in survival outcomes.

Global External Defibrillators Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

External Defibrillators Market Regional Outlook

North America

North America remains the dominant region, holding approximately 46% of the global market share. Over 850,000 AEDs are deployed in the U.S. alone, and more than 110,000 in Canada. The region records about 356,000 out-of-hospital cardiac arrests annually, with survival rates improving to 12% due to AED access. Federal programs like “HeartRescue” have funded AED installations across 1,200 communities. In the U.S., nearly 92% of hospitals possess advanced defibrillation systems, while public installation density averages 3.5 devices per 10,000 residents.

Europe

Europe accounts for around 28% of the total market, supported by national initiatives such as the UK’s Public Access Defibrillation Project and Germany’s “Save a Life” campaign. More than 400,000 AEDs are installed across the EU. Approximately 75% of European hospitals have integrated defibrillators connected to internal emergency systems. The UK alone reports 30,000 annual cardiac arrests, with survival rates exceeding 18% in AED-accessible zones. Demand for wearable defibrillators is growing, with over 20,000 units in active use as of 2025.

Asia-Pacific

Asia-Pacific holds about 21% market share, with Japan leading regional adoption. Japan maintains over 600,000 public AEDs — the highest in the world. China has installed over 210,000 AEDs, while India has deployed more than 50,000 units in metropolitan areas. The region’s cardiac arrest incidence exceeds 1.8 million annually, driving government-led initiatives for emergency response systems. Australia and South Korea have both achieved 25% growth in AED installation density over the past three years.

Middle East & Africa

The Middle East & Africa collectively account for roughly 5% of the global market. Countries like Saudi Arabia, UAE, and South Africa are expanding public defibrillator networks. The UAE has installed more than 7,500 AEDs in public locations, while Saudi Arabia recently mandated AED availability in large organizations employing over 250 people. Africa’s deployment remains limited, with AED availability below 2 devices per 100,000 population, though international aid programs have distributed over 15,000 AEDs since 2023.

List of Top External Defibrillators Companies

  • Osatu (Mondragon)
  • Nihon Kohden
  • Laerdal Medical
  • Boston Scientific
  • GE Healthcare
  • Physio-Control
  • Defibtech
  • HeartSine Technologies
  • Cardiac Science

Top Two Companies with Highest Share

  • Philips Healthcare: Holds an estimated 24% market share, supported by wide global distribution and over 1 million AED installations worldwide.
  • ZOLL Medical Corporation: Maintains approximately 21% share with strong presence in both clinical and public access sectors.

Investment Analysis and Opportunities

Global investment in the External Defibrillators Market has intensified as governments and private organizations prioritize cardiac safety. Approximately 37 countries have enacted mandates requiring AEDs in schools, fitness centers, and public institutions. Venture capital investments in connected defibrillator startups exceeded 45 new deals between 2023–2025. Hospitals are allocating up to 18% of emergency equipment budgets for AED upgrades. Additionally, AI-driven monitoring platforms have attracted investments exceeding 120 partnerships worldwide. With increasing awareness, the corporate segment is expected to install over 100,000 AEDs in workplaces by 2026, reflecting growing External Defibrillators Market Opportunities across industries.

New Product Development

Between 2023 and 2025, the External Defibrillators Market witnessed rapid innovation. Over 30 new models introduced include self-diagnosing systems and cloud-connected platforms. Philips launched its HeartStart FRx2 with smart connectivity in 2024, enhancing data transfer efficiency by 45%. ZOLL introduced its AED 5 Pro, offering 99% accuracy in rhythm recognition. Nihon Kohden released a multi-language voice-guided AED designed for global deployment, adopted by over 500 institutions in 12 months. AI-based predictive defibrillators that integrate patient ECG history now represent 22% of the total hospital market. Development of lightweight portable AEDs under 2.5 kg has further expanded accessibility.

Five Recent Developments (2023–2025)

  • 2025: ZOLL launched cloud-linked AED 5 Pro with self-test analytics, reducing device downtime by 30%.
  • 2024: Philips Healthcare released HeartStart FRx2 AED with enhanced smart response algorithms.
  • 2024: Nihon Kohden developed AI-based AED system achieving 99% diagnostic accuracy.
  • 2023: Laerdal Medical introduced compact community AEDs for rapid-response networks across 500 cities.
  • 2023: GE Healthcare integrated IoT monitoring with centralized hospital defibrillation systems covering 1,200 facilities.

Report Coverage of External Defibrillators Market

The External Defibrillators Market Research Report provides a detailed examination of device types, regional distribution, key players, technological trends, and clinical applications. It includes analysis of over 30 countries and market data from 2018–2025. The External Defibrillators Market Report covers adoption patterns across hospitals, ambulances, and public installations, alongside product benchmarking for major manufacturers. Data encompasses unit volumes, installation density, product life cycles, and device interoperability insights. The report emphasizes External Defibrillators Market Insights for business strategies, investment planning, and product development, offering stakeholders a comprehensive view of technological progress, regulatory standards, and future growth opportunities across the global External Defibrillators Industry.

External Defibrillators Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 6474.31 Million in 2026

Market Size Value By

USD 13144.57 Million by 2035

Growth Rate

CAGR of 8.19% from 2026 - 2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Automatic Type
  • Manually Type

By Application :

  • Pulseless Ventricular Tachycardia
  • Ventricular Fibrillation

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global External Defibrillators Market is expected to reach USD 13144.57 Million by 2035.

The External Defibrillators Market is expected to exhibit a CAGR of 8.19% by 2035.

Osatu (Mondragon),Nihon Kohden,Laerdal Medical,ZOLL,Philips Healthcare,BOSTON SCIENTIFIC,Zoll,GE Healthcare,Physio-Control,Defibtech,HeartSine Technologies,Cardiac Science.

In 2025, the External Defibrillators Market value stood at USD 5984.2 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified